Compare AEM & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEM | MCK |
|---|---|---|
| Founded | 1953 | 1833 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.6B | 101.9B |
| IPO Year | N/A | N/A |
| Metric | AEM | MCK |
|---|---|---|
| Price | $196.37 | $851.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | $223.71 | ★ $882.69 |
| AVG Volume (30 Days) | ★ 3.0M | 594.6K |
| Earning Date | 02-12-2026 | 02-04-2026 |
| Dividend Yield | ★ 0.84% | 0.39% |
| EPS Growth | ★ 237.78 | 66.19 |
| EPS | 6.84 | ★ 32.12 |
| Revenue | $10,567,578,000.00 | ★ $387,094,000,000.00 |
| Revenue This Year | $42.18 | $14.84 |
| Revenue Next Year | $19.44 | $8.34 |
| P/E Ratio | $27.89 | ★ $26.36 |
| Revenue Growth | ★ 35.16 | 17.23 |
| 52 Week Low | $92.11 | $570.51 |
| 52 Week High | $225.00 | $895.58 |
| Indicator | AEM | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 50.30 | 62.44 |
| Support Level | $187.04 | $818.70 |
| Resistance Level | $225.00 | $849.05 |
| Average True Range (ATR) | 8.69 | 17.22 |
| MACD | -2.58 | 2.35 |
| Stochastic Oscillator | 24.58 | 91.18 |
Agnico Eagle is a gold miner with mines in Canada, Mexico, Finland, and Australia. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines online in rapid succession in the following years. It merged with Kirkland Lake Gold in 2022, acquiring the Detour Lake and Macassa mines in Canada along with the high-grade, low-cost Fosterville mine in Australia. It sold around 3.4 million gold ounces in 2024 and had about 15 years of gold reserves at end 2024. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions and bought the remaining 50% of its Canadian Malartic mine along with the Wasamac project and other assets from Yamana Gold in 2023.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.